[{"Assets_0_Q1_USD":166763000.0,"CommonStockSharesOutstanding_0_Q1_shares":24115000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-6759000.0,"NetIncomeLoss_1_Q1_USD":-9016000.0,"StockholdersEquity_0_Q1_USD":152394000.0,"Ticker":"CRNX","CIK":"1658247","name":"CRINETICS PHARMACEUTICALS, INC.","OfficialName":"Crinetics Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1104302360.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190513"}]